Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Altor BioScience
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Endo Pharmaceuticals
Bioniche Life Sciences Inc.
Ohio State University